Immunogenicity 13343
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
CNGA1
Transcript ID
uc003gxu.3
HLA INFO
B*38:01
TCR INFO
No TCR info found!
Full length protein sequence (759 aa)
MESRS
1
SPRLE
6
CSGAI
11
SAHCS
16
LHLPD
21
SSDFQ
26
LIFVF
31
LVEMG
36
FHHVG
41
QAGLE
46
LLISS
51
DLPTS
56
ASQSA
61
GITDM
66
KLSMK
71
NNIIN
76
TQQSF
81
VTMPN
86
VIVPD
91
IEKEI
96
RRMEN
101
GACSS
106
FSEDD
111
DSAST
116
SEESE
121
NENPH
126
ARGSF
131
SYKSL
136
RKGGP
141
SQREQ
146
YLPGA
151
IALFN
156
VNNSS
161
NKDQE
166
PEEKK
171
KKKKE
176
KKSKS
181
DDKNE
186
NKNDP
191
EKKKK
196
KKDKE
201
KKKKE
206
EKSKD
211
KKEEE
216
KKEVV
221
VIDPS
226
GNTYY
231
NWLFC
236
ITLPV
241
MYNWT
246
MVIAR
251
ACFDE
256
LQSDY
261
LEYWL
266
ILDYV
271
SDIVY
276
LIDMF
281
VRTRT
286
GYLEQ
291
GLLVK
296
EELKL
301
INKYK
306
SNLQF
311
KLDVL
316
SLIPT
321
DLLYF
326
KLGWN
331
YPEIR
336
LNRLL
341
RFSRM
346
FEFFQ
351
RTETR
356
TNYPN
361
IFRIS
366
NLVMY
371
IVIII
376
HWNAC
381
VFYSI
386
SKAIG
391
FGNDT
396
WVYPD
401
INDPE
406
FGRLA
411
RKYVY
416
SLYWS
421
TLTLT
426
TIGET
431
PPPVR
436
DSEYV
441
FVVVD
446
FLIGV
451
LIFAT
456
IVGNI
461
GSMIS
466
NMNAA
471
RAEFQ
476
ARIDA
481
IKQYM
486
HFRNV
491
SKDME
496
KRVIK
501
WFDYL
506
WTNKK
511
TVDEK
516
EVLKY
521
LPDKL
526
RAEIA
531
INVHL
536
DTLKK
541
VRIFA
546
DCEAG
551
LLVEL
556
VLKLQ
561
PQVYS
566
PGDYI
571
CKKGD
576
IGREM
581
YIIKE
586
GKLAV
591
VADDG
596
VTQFV
601
VLSDG
606
SYFGE
611
ISILN
616
IKGSK
621
AGNRR
626
TANIK
631
SIGYS
636
DLFCL
641
SKDDL
646
MEALT
651
EYPDA
656
KTMLE
661
EKGKQ
666
ILMKD
671
GLLDL
676
NIANA
681
GSDPK
686
DLEEK
691
VTRME
696
GSVDL
701
LQTRF
706
ARILA
711
EYESM
716
QQKLK
721
QRLTK
726
VEKFL
731
KPLID
736
TEFSS
741
IEGPG
746
AESGP
751
IDST
756
Mutation Information
DNA mutation:
None
Peptide Range:
686 ~ 710
Mut AA position:
None (None in Wild Type peptide)
Alignment
Wild Type:
"GSDPKDLEEKVTRMEGSVDLLQTRF
||||||||||||.||||||||||||
Mutant:
GSDPKDLEEKVTQMEGSVDLLQTRF"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) CNGA1
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay